title: Comment on: A case of certolizumab-induced interstitial lung disease in a patient with rheumatoid arthritis.
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital, Belfast and Department of Rheumatology, Antrim Area Hospital, Antrim, UK.Department of Rheumatology, Musgrave Park Hospital, Belfast and Department of Rheumatology, Antrim Area Hospital, Antrim, UK. savageeimear@gmail.com.
authors.forename: Eimear M
authors.initials: EM
authors.lastname: Savage
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital, Belfast and Department of Rheumatology, Antrim Area Hospital, Antrim, UK.Department of Rheumatology, Musgrave Park Hospital, Belfast and Department of Rheumatology, Antrim Area Hospital, Antrim, UK.
authors.forename: Auleen M
authors.initials: AM
authors.lastname: Millar
authors.affiliation: Department of Rheumatology, Musgrave Park Hospital, Belfast and Department of Rheumatology, Antrim Area Hospital, Antrim, UK.
authors.forename: Allister J
authors.initials: AJ
authors.lastname: Taggart
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000009:adverse effects*; D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000009:adverse effects*; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D011092:Polyethylene Glycols / Q000009:adverse effects*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D007140:Immunoglobulin Fab Fragments; D007166:Immunosuppressive Agents; D011092:Polyethylene Glycols